Now, one type of weight-loss medication is proving helpful with another health issue. In a study published Feb. 12 in JAMA Psychiatry, researchers report that semaglutide, better known as Ozempic or Wegovy, helped people with alcohol addiction reduce their craving and drink less.

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol cravings and consumption.